Low serum testosterone and estradiol predict mortality in elderly men.

CONTEXT Age-related reduction of serum testosterone may contribute to the signs and symptoms of aging, but previous studies report conflicting evidence about testosterone levels and male mortality. No large prospective cohort study has determined a possible association between serum estradiol and mortality in men. OBJECTIVE The main objective was to examine the association between serum testosterone and estradiol and all-cause mortality in elderly men. DESIGN, SETTING, AND PARTICIPANTS We used specific gas chromatography-mass spectrometry to analyze serum sex steroids at baseline in older men who participated in the prospective population-based MrOS Sweden cohort (n = 3014; mean age, 75 yr; range, 69-80 yr). MAIN OUTCOME MEASURE All-cause mortality by serum testosterone and estradiol levels. RESULTS During a mean follow-up period of 4.5 yr, 383 deaths occurred. In multivariate hazards regression models, low levels (within quartile 1 vs. quartiles 2-4) of both testosterone [hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.29-2.12] and estradiol (HR, 1.54; 95% CI, 1.22-1.95) associated with mortality. A model including both hormones showed that both low testosterone (HR, 1.46; 95% CI, 1.11-1.92) and estradiol (HR, 1.33; 95% CI, 1.02-1.73) predicted mortality. Risk of death nearly doubled (HR, 1.96; 95% CI, 1.46-2.62) in subjects with low levels of both testosterone and estradiol compared with subjects within quartiles 2-4 of both hormones. CONCLUSIONS Elderly men with low serum testosterone and estradiol have increased risk of mortality, and subjects with low values of both testosterone and estradiol have the highest risk of mortality.

[1]  A. Araujo,et al.  The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. , 2009, The Journal of clinical endocrinology and metabolism.

[2]  B. Clarke.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2009 .

[3]  R. Huupponen,et al.  Serum testosterone but not leptin predicts mortality in elderly men. , 2008, Age and ageing.

[4]  J. Eisman,et al.  Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. , 2008, Archives of internal medicine.

[5]  D. Grobbee,et al.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.

[6]  E. Barrett-Connor,et al.  Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  P. Snyder.  Might testosterone actually reduce mortality? , 2008, The Journal of clinical endocrinology and metabolism.

[8]  A. Dobs,et al.  Testosterone making an entry into the cardiometabolic world. , 2007, Circulation.

[9]  M. Dowsett,et al.  Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.

[10]  L. Lönn,et al.  Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  A. Araujo,et al.  Sex steroids and all-cause and cause-specific mortality in men. , 2007, Archives of internal medicine.

[12]  Claes Ohlsson,et al.  Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  S. Cummings,et al.  Endogenous testosterone levels, physical performance, and fall risk in older men. , 2006, Archives of internal medicine.

[14]  S. Cummings,et al.  Comparison of methods to measure low serum estradiol levels in postmenopausal women. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  D. Kivlahan,et al.  Low serum testosterone and mortality in male veterans. , 2006, Archives of internal medicine.

[16]  P. Bélanger,et al.  Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[19]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[20]  Yoav Ben-Shlomo,et al.  Cortisol, Testosterone, and Coronary Heart Disease: Prospective Evidence From the Caerphilly Study , 2005, Circulation.

[21]  A. Karagiannis,et al.  Gonadal dysfunction in systemic diseases. , 2005, European journal of endocrinology.

[22]  J. Tuomilehto,et al.  Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  D. Kivlahan,et al.  Low Testosterone Is Associated with Decreased Function and Increased Mortality Risk: A Preliminary Study of Men in a Geriatric Rehabilitation Unit , 2004, Journal of the American Geriatrics Society.

[24]  J. Bilezikian,et al.  Aromatase activity and bone homeostasis in men. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  Christina Wang,et al.  Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. , 2004, The Journal of clinical endocrinology and metabolism.

[26]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[27]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[28]  H. Krumholz,et al.  An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. , 2001, Archives of internal medicine.

[29]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  G A Colditz,et al.  Guidelines for healthy weight. , 1999, The New England journal of medicine.

[32]  R. Klein,et al.  Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic Retinopathy , 1996, Diabetes Care.

[33]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[34]  E. Barrett-Connor,et al.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.